PTC Therapeutics' Kebilidi gains FDA accelerated approval as the first brain-administered gene therapy in the U.S. for AADC ...

Neonatal encephalopathy, a condition resulting from perinatal asphyxia, occurs in 2.0–6.0 of every 1000 live births. Without treatment, prognosis is poor and resulting complications such as ...